What is Rigel Pharmaceuticals's EV / sales?

Rigel Pharmaceuticals (RIGL) reported EV / sales of 1.8× in Q1 2026.

How has Rigel Pharmaceuticals's EV / sales changed year-over-year?

Rigel Pharmaceuticals's EV / sales increased by 33.0% year-over-year, from 1.4× to 1.8×.

What is the long-term trend for Rigel Pharmaceuticals's EV / sales?

Over 5 years (2020 to 2025), Rigel Pharmaceuticals's EV / sales has grown at a -12.4% compound annual growth rate (CAGR), from 5.4× to 2.8×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Rigel Pharmaceuticals RIGL EV / sales

EV / sales at other companies

AmgenAMGN

6.6×+0.1×

Agios PharmaceuticalsAGIO

28.8×-15.8×

Nuvation BioNUVB

9.9×-41.1×

RegenxbioRGNX

5.6×+3.6×

Zevra Therapeutics, Inc.ZVRA

3.7×-6.9×

Gyre Therapeutics, Inc.GYRE

5.1×-1.9×

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

enterprise value/total revenue=1.8×

Based on the most recent quarter.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's EV / sales?: Rigel Pharmaceuticals (RIGL) reported EV / sales of 1.8× in Q1 2026.
How has Rigel Pharmaceuticals's EV / sales changed year-over-year?: Rigel Pharmaceuticals's EV / sales increased by 33.0% year-over-year, from 1.4× to 1.8×.
What is the long-term trend for Rigel Pharmaceuticals's EV / sales?: Over 5 years (2020 to 2025), Rigel Pharmaceuticals's EV / sales has grown at a -12.4% compound annual growth rate (CAGR), from 5.4× to 2.8×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.